Robotic Arm Assisted Total Knee Arthroplasty

NCT02058069 | Completed Results

• 2 other identifiers: RIOTKA_201420131148
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 3

Brief Summary

The Investigation will be conducted as a single-submission, multi-center study with approval from and in compliance of the Western Institutional Review Board (WIRB). The overall objective of this Investigation is to assess the safety and effectiveness of the Robotic Arm Interactive Orthopedic System (RIO) Total Knee Arthroplasty Application. Specifically, the study objectives are classified as follows:

• Primary Objective: Surgeon assessment of standardized TKA complications both intra-operatively and at short term follow up.
• Secondary Objective: Radiographic assessment of post-operative limb alignment.
• Supporting Objective: Patient assessment of post-operative function and satisfaction.

Conditions

Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis

Outcome Measures

Primary Outcomes (3)

• Intra-Operative Complications

  Surgeon assessment of standardized TKA complications (Healey et al. CORR 2012) both intra-operatively and at short term follow up. The nine complications relating to soft tissue damage for primary TKA that were assessed as part of this study were as follows: Blood loss, Vascular injury, MCL injury, Periprosthetic fracture, Extensor mechanism disruption, Patellofemoral dislocation, Tibiofemoral dislocation, Neurological impairment, Instability.

  Subject will be assessed for these complications intra-operatively. The assessment occurs after the surgeon has completed the surgical procedure, but while the subject is still in the operating room with the surgeon.

• Intra-Operative Complications

  Surgeon assessment of standardized TKA complications (Healey et al. CORR 2012) both intra-operatively and at short term follow up. The nine complications relating to soft tissue damage for primary TKA that were assessed as part of this study were as follows: Blood loss, Vascular injury, MCL injury, Periprosthetic fracture, Extensor mechanism disruption, Patellofemoral dislocation, Tibiofemoral dislocation, Neurological impairment, Instability.

  Subjects will be assessed for incidence of intra-operative complications at the conclusion of their hospital stay, or an average of 3 days post-operatively.

• Intra-Operative Complications

  Surgeon assessment of standardized TKA complications (Healey et al. CORR 2012) both intra-operatively and at short term follow up. The nine complications relating to soft tissue damage for primary TKA that were assessed as part of this study were as follows: Blood loss, Vascular injury, MCL injury, Periprosthetic fracture, Extensor mechanism disruption, Patellofemoral dislocation, Tibiofemoral dislocation, Neurological impairment, Instability.

  3 Month Post Op

Secondary Outcomes (2)

• Change in the Radiographic Assessment of Limb Alignment From Pre-Operative to 3 Months Post-Operative

  pre-op plan, 3 Month Post Op

• Participants With Limb Alignment Difference <4.38 Degrees

  Pre-op Plan, 3 Month Post Op

Other Outcomes (1)

• Patient Satisfaction - Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC)

  Pre-Op, 3 Month Post Op [change assessed between the two time periods]

Study Arms (1)

Robotic Assisted Total Knee Arthroplasty

EXPERIMENTAL

Device: Robotic Arm Assisted Total Knee Arthroplasty

Interventions

Robotic Arm Assisted Total Knee Arthroplasty DEVICE

The total knee implant system used for this study was the Kinetis implant system (MAKO Surgical Corp.).

Also known as: MAKO Surgical Corp, RIO Total Knee Arthroplasty Application, MAKOplasty Total Knee Arthroplasty

Robotic Assisted Total Knee Arthroplasty

Eligibility Criteria

• Age: 21 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Male or female subjects may be recruited in to the Investigation.
• Age - The subject must be at least 21 years of age and skeletally mature as demonstrated radiographically by complete closure of the distal femoral and proximal tibial epiphyses.
• Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
• Subjects who, in the opinion of the Investigators and Approved Study Staff, are able to understand this Investigation and cooperate with the Investigation procedures and are willing to comply with all the required post-operative follow-ups.
• Subjects who require a total knee arthroplasty for primary surgical management of osteoarthritis, post-traumatic arthritis, rheumatoid arthritis, moderate deformities or femoral condyle osteonecrosis as defined below.
• Osteoarthritis: Kellgren-Lawrence Grade 3 or higher, with clinical history of an absence of major trauma to the joint; symptoms of pain, stiffness, swelling, and/or loss of motion; and with radiographic evidence of joint space narrowing, sub-chondral sclerosis, or peripheral osteophytes.
• Post-Traumatic Arthritis: Kellgren-Lawrence Grade 3 or higher, with a clinical history of trauma to the targeted knee and subsequent pain, stiffness, swelling and loss of motion; and with radiographic evidence of joint space narrowing, sub-chondral sclerosis, or peripheral osteophytes.
• Rheumatoid Arthritis: American College of Rheumatology classification score of 6 or higher, with a clinical history that demonstrates the following: morning stiffness for at least 1 hour and present for at least 6 weeks, swelling, loss of motion, and/or serum rheumatoid factor; and radiographic findings of narrow joint space, peri-articular osteopenia, and/or per-articular erosions.
• Moderate Deformities: Moderate varus, valgus, flexion, or post-traumatic deformities of no more than 15° assessed radiographically. Moderate recurvatum of no more than 8° assessed radiographically.
• Femoral Condyle Osteonecrosis: Loss of blood supply in the femoral condyle characterized by sudden onset of pain, possibly triggered by a specific seemingly routine activity or minor injury. Pain is often increased with activity and at night time and may cause swelling of the knee and sensitivity to touch and pressure and may result in limited motion. Confirmed by a bone scan, MRI, and/or x-ray.
• Subjects whose anatomy is appropriate for the available range of implant sizes.

You may not qualify if:

• Patients who have had previous surgical procedures requiring implantation of hardware in their operative side knee, hip, or ankle that would result in metal artifact scatter in a CT scan.
• Patients who have a fracture malunion of the distal femur or proximal tibia within 12cm of the knee center, assessed radiographically.
• Patients who are pregnant, may become pregnant during the course of the Investigation, or are currently lactating.
• Patients with allergies or suspected sensitivity to any patient-contacting component of the investigational device or the implant to be used in the study as listed below:
• Femoral component: Cobalt Chromium alloy (CoCr)
• Tibial component: Titanium alloy (Ti6Al4V)
• Tibial inserts and patella component: Vitamin E infused ultra-high molecular weight polyethylene (UHMWPE)
• Saw blade: 440C Stainless Steel
• Patients who require bilateral total knee arthroplasty.
• Patients who are currently on medical leave from their employment due to Workmen's Compensation.
• Patients who are currently state or federal prisoners.
• Patients who are currently Wards of the state.
• Patients who are at high risk for poor healing or confounding outcomes or at excessive risk for surgery i.e.: clinically significant/being actively treated for renal, hepatic, cardiac, hematologic, or neurologic disease or poorly controlled diabetes (HbA1c \> 10 mg/dL) or previous history of joint infection.
• Patients who are known drug or alcohol abusers or with psychological disorders as defined by DSM V that could affect follow-up care or treatment outcomes.
• Patients who are currently involved in another clinical study with an investigational device.

Sponsors & Collaborators

• MAKO Surgical Corp.: lead

Study Sites (3)

Coon Joint Replacement Institue; St. Helena Hospital

St. Helena, California, 94574, United States

Location

Florida Orthopedic Institute

Tampa, Florida, 33637, United States

Location

Memorial Bone and Joint Research Foundation; Memorial Hermann Memorial City Medical Center

Houston, Texas, 77024, United States

Location

MeSH Terms

Conditions

Osteoarthritis; Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases

Results Point of Contact

• Title: Michael Conditt
• Organization: MAKO Surgical Corp.

michael.conditt@stryker.com

7132408675

Study Officials

• Kenneth Gustke, MD

  Florida Orthopedic Institute, Tampa General Hospital

  PRINCIPAL INVESTIGATOR

• Thomas Coon, MD

  Coon Joint Replacement Institute, St. Helena Hospital

  PRINCIPAL INVESTIGATOR

• Stefan Kreuzer, MD

  Memorial Bone and Joint Research Foundation, Memorial Hermann Medical Center

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restriction Type: GT60
• Restrictive Agreement: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 3, 2014
• First Posted: February 7, 2014
• Study Start: February 1, 2014
• Primary Completion: January 1, 2015
• Study Completion: January 1, 2015
• Last Updated: April 18, 2017
• Results First Posted: February 12, 2016

Record last verified: 2017-03

Locations

US (3)